Clinical Trial Update: Nitric Oxide Therapy for Acute Chest Syndrome in Sickle Cell Disease Children [Phase 2]

View source ↗

Summary

Phase 2 trial evaluated inhaled nitric oxide for treating Acute Chest Syndrome in children with Sickle Cell Disease; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chest Syndrome
• Sickle Cell Disease

Drugs mentioned

• Nitric Oxide (nitric oxide)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Acute Chest Syndrome, Sickle Cell Disease | Phase 2 | Status: COMPLETED